Thailand - Delayed Quote THB

Bumrungrad Hospital Public Company Limited (BH.BK)

248.00 -5.00 (-1.98%)
At close: April 26 at 4:36 PM GMT+7
Key Events
Loading Chart for BH.BK
DELL
  • Previous Close 253.00
  • Open 251.00
  • Bid 248.00 x --
  • Ask 249.00 x --
  • Day's Range 246.00 - 252.00
  • 52 Week Range 210.00 - 272.00
  • Volume 4,192,022
  • Avg. Volume 2,198,306
  • Market Cap (intraday) 197.139B
  • Beta (5Y Monthly) 0.21
  • PE Ratio (TTM) 29.07
  • EPS (TTM) 8.53
  • Earnings Date May 2, 2024
  • Forward Dividend & Yield 4.50 (1.81%)
  • Ex-Dividend Date Mar 13, 2024
  • 1y Target Est 278.58

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics. In addition, it provides spine institute, diagnostic radiology and nuclear medicine, esperance, heart institute, intensive care unit, neurocritical care, nutrition services, pharmacy services, and preventive genomics and integrative medicine services. Further, the company offers clinical research; hospital consulting and management; healthcare personnel development and training; healthcare referral; and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.

www.bumrungrad.com

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: BH.BK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BH.BK
13.28%
MSCI WORLD
5.23%

1-Year Return

BH.BK
4.46%
MSCI WORLD
19.56%

3-Year Return

BH.BK
91.55%
MSCI WORLD
0.00%

5-Year Return

BH.BK
56.19%
MSCI WORLD
54.02%

Compare To: BH.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BH.BK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    197.14B

  • Enterprise Value

    184.44B

  • Trailing P/E

    29.04

  • Forward P/E

    25.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.32

  • Price/Book (mrq)

    7.64

  • Enterprise Value/Revenue

    7.14

  • Enterprise Value/EBITDA

    17.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    27.43%

  • Return on Assets (ttm)

    19.81%

  • Return on Equity (ttm)

    31.99%

  • Revenue (ttm)

    25.55B

  • Net Income Avi to Common (ttm)

    7.01B

  • Diluted EPS (ttm)

    8.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.75B

  • Total Debt/Equity (mrq)

    0.38%

  • Levered Free Cash Flow (ttm)

    3.69B

Research Analysis: BH.BK

Analyst Price Targets

235.00 Low
278.58 Average
248.00 Current
313.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: BH.BK

People Also Watch